5NCCLS. How to Define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline[M]. 2th ed. Pennsylva- nia : NCCLS, 2000.
6Qin X,Lin L,Mo Z,et al. Reference intervals for serum alpha fe oprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examina Lion Survey[J]. Int J Biol Markers,2011,26(1) : 65.
7Bjerner J, H.getveit A,Wold Akselberg K, et al. Reference in-tervals for carcinoembryonic antigen (CEA), CA125, MUC1, AI- fa-foeto-protein ( AFP), neuron-specific enolase ( NSE ) and CA19.9 from the NORIP study[J]. Seand J Clin Lab Invest, 2008,68(8) :703.
8Woo H Y, Kim YJ,Park H. Establishment of reference intervals of tumor markers in Korean adults[J]. Korean J Lab Med, 2008,28 (3)..179.
9Schwegler EE,Cazaresl,Steel LF. SELDI-TOF MS Profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma[J].HEPATOLOGY,2005,(03):634-642.
10Mao Y,Yang H,Xu H. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].GUT,2010,(12):1687-1693.
